A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma
- Resource Type
- Article
- Authors
- Sacco, Joseph J.; Jackson, Richard; Corrie, Pippa; Danson, Sarah; Evans, T.R. Jeffry; Ochsenreither, Sebastian; Kumar, Satish; Goodman, Andrew; Larkin, James; Karydis, Ioannis; Steven, Neil; Lorigan, Paul; Plummer, Ruth; Patel, Poulam; Psarelli, Eftychia; Olsson-Brown, Anna; Shaw, Heather; Leyvraz, Serge; Handley, Louise; Rawcliffe, Charlotte; Nathan, Paul
- Source
- In European Journal of Cancer May 2024 202
- Subject
- MSC
- Language
- ISSN
- 0959-8049